Can Belantamab mafodotin cause macro LDH?
= 0.045). This study provides the first report of potentially Belamaf-associated Macro-LDH formation. Awareness of this benign phenomenon is essential to prevent unnecessary diagnostic investigations, thereby reducing patient burden and healthcare costs.
Authors
- Svetlana Trestman
- Natan Melamed
- Tamir Shragai (ORCID: https://orcid.org/0000-0002-3741-689X)
- Eyal Hassoun
- Yaël Cohen (ORCID: https://orcid.org/0000-0003-4182-1860)
- Leehe Hakakian
- Irit Avivi
- Ben-Zion Katz
- Nidaa Arafat
Institutions
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-04-16
- DOI
- https://doi.org/10.1080/10428194.2026.2649877
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00